Related Experiment Video
Updated: Apr 17, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
20.2K
Stereotactic Radiosurgery as the Initial Treatment for Patients with Nonfunctioning Pituitary Adenomas
Toshinori Hasegawa1, Kazunori Shintai1, Takenori Kato1
1Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, Komaki, Japan.
World Neurosurgery
|February 22, 2015
Summary
Gamma Knife Surgery (GKS) effectively controls nonfunctioning pituitary adenomas (NFPAs), offering a safe initial treatment. This study confirms tumor regression and minimal adverse effects, preserving pituitary function in most patients.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Endocrinology
Background:
- Nonfunctioning pituitary adenomas (NFPAs) are common intracranial tumors.
- Management often involves surgery, but stereotactic radiosurgery is an alternative.
- Optimal treatment aims for tumor control and preservation of pituitary function.
Purpose of the Study:
- To evaluate the efficacy and safety of Gamma Knife Surgery (GKS) as an initial treatment for NFPAs.
- To determine the optimal radiation dose for long-term tumor control and pituitary function preservation.
- To assess the risk of adverse effects associated with GKS for NFPAs.
Main Methods:
- Retrospective analysis of 16 patients with primary NFPAs treated with GKS.
- Median tumor volume: 2.0 cm³; median margin dose: 15 Gy.
- Focus on tumors with suprasellar extension and optic apparatus compression.
Main Results:
- 98-month median follow-up.
- Tumor regression in 15/16 patients; 1 stable tumor; no progression.
- No cranial nerve injury or secondary neoplasms; one patient required hormone replacement post-treatment.
Conclusions:
- GKS is a safe and effective initial treatment for NFPAs, particularly in elderly or comorbid patients.
- Careful treatment planning can minimize risks like hypopituitarism and optic neuropathy.
- GKS offers a viable option for long-term tumor control with preserved pituitary function.
